As of 2025-07-13, the Relative Valuation of Algernon Pharmaceuticals Inc (AGN.CN) is 0.03 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 CAD, the upside of Algernon Pharmaceuticals Inc based on Relative Valuation is -49.5%.
The range of the Relative Valuation is 0.03 - 0.04 CAD.
| Range | Selected | |
| Trailing P/E multiples | 2.8x - 4.2x | 3.5x |
| Forward P/E multiples | 2.8x - 4.2x | 3.5x |
| Fair Price | 0.03 - 0.04 | 0.03 |
| Upside | -59.3% - -39.7% | -49.5% |
| Date | P/E |
| 2025-07-09 | 7.47 |
| 2025-07-07 | 7.47 |
| 2025-07-04 | 7.47 |
| 2025-07-02 | 6.93 |
| 2025-06-30 | 6.40 |
| 2025-06-26 | 7.47 |
| 2025-06-25 | 6.93 |
| 2025-06-24 | 7.47 |
| 2025-06-23 | 6.93 |
| 2025-06-19 | 7.47 |
| 2025-06-18 | 7.47 |
| 2025-06-17 | 7.47 |
| 2025-06-16 | 10.13 |
| 2025-06-13 | 10.13 |
| 2025-06-12 | 10.13 |
| 2025-06-11 | 10.13 |
| 2025-06-10 | 9.60 |
| 2025-06-09 | 9.07 |
| 2025-06-06 | 9.07 |
| 2025-06-05 | 8.53 |
| 2025-06-04 | 8.53 |
| 2025-06-02 | 8.00 |
| 2025-05-30 | 8.53 |
| 2025-05-29 | 8.53 |
| 2025-05-28 | 8.00 |
| 2025-05-27 | 8.53 |
| 2025-05-26 | 9.07 |
| 2025-05-23 | 9.07 |
| 2025-05-22 | 9.60 |
| 2025-05-21 | 9.07 |
| 2025-05-20 | 9.07 |
| 2025-05-16 | 9.60 |
| 2025-05-15 | 9.60 |
| 2025-05-14 | 9.07 |
| 2025-05-13 | 9.60 |
| 2025-05-12 | 9.60 |
| 2025-05-09 | 9.07 |
| 2025-05-08 | 9.07 |
| 2025-05-07 | 9.07 |
| 2025-05-06 | 8.53 |
| 2025-05-05 | 9.07 |
| 2025-05-02 | 8.53 |
| 2025-04-30 | 9.07 |
| 2025-04-29 | 9.07 |
| 2025-04-28 | 9.07 |
| 2025-04-25 | 9.07 |
| 2025-04-24 | 8.53 |
| 2025-04-23 | 8.53 |
| 2025-04-22 | 8.53 |
| 2025-04-21 | 9.07 |